P2X7 receptor promotes migration and invasion of non-small cell lung cancer A549 cells through the PI3K/Akt pathways

It has been demonstrated that the ATP-gated ion channel P2X7 Receptor is involved in tumor progression and plays an important role in regulating tumor cell growth, invasion, migration and angiogenesis. However, P2X7 receptors have been relatively poorly studied in non-small cell lung Cancer (NSCLC) cells. Therefore, the aim of this study was to investigate the effects of P2X7 Receptor on A549 cells (NSCLC cell line) migration and invasion and to reveal the molecular mechanisms mediated by it. We detected the expression and function of P2X7 Receptor in A549 cells. The effects and mechanisms of P2X7 Receptor on A549 cells migration, invasion, and epithelial-mesenchymal transition were detected in vitro and in vivo. The results showed P2X7 Receptor expressed by A549 cells had ion channel and macropore formation function. In addition, activation of P2X7 Receptor by adenosine triphosphate (ATP) or 2'(3')-O-(4-Benzoylbenzoyl)-adenosine-5'-triphosphate (BzATP) promoted Epithelial-mesenchymal transition (EMT), migration and invasion of A549 cells, which was attenuated by treatment of cells with P2X7 Receptor Antagonist A438079 and Oxidized ATP. Furthermore, activation of P2X7 Receptor increased phosphorylated protein kinase B (p-Akt) levels, and the phosphatidylinositol-tris-phosphate kinase 3 (PI3K)/protein kinase B (Akt) inhibitor LY294002 blocked migration and invasion of A549 cells induced by ATP or BzATP. At the same time, in vivo results showed that P2X7 Receptor could also promote EMT and PI3K/Akt expression in transplanted tumors. Our study indicated that P2X7 Receptor promotes A549 cells migration and invasion through the PI3K/Akt signaling pathway, suggesting that P2X7 Receptor may be a potential therapeutic target for NSCLC.

Invasion; Migration; Non-small cell lung cancer; P2X7 receptor; PI3K/Akt signaling pathway.